Rein Therapeutics Debt-to-Assets Ratio Growth & History (RNTX)

Rein Therapeutics's debt-to-assets ratio was 0.00 for fiscal 2024.

View full Rein Therapeutics company overview

Rein Therapeutics annual debt-to-assets ratio history

Rein Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20242024-12-310.00−0.00
20232023-12-310.00−0.00−79.24%
20222022-12-310.00−0.00−34.73%
20212021-12-310.00
20192019-12-310.190.01+6.70%
20182018-12-310.18

Rein Therapeutics debt-to-assets ratio trends

Over the last five fiscal years, Rein Therapeutics's debt-to-assets ratio decreased from 0.19 to 0.00, a change of −0.19. The latest reported quarter, Q1 2026, shows 0.19.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rein Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about RNTX yet. Start the conversation.

Write the first post